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Ganglion cellIn order to approach the function of the retinal dystrophy CERKL gene we generated a novel knockout mouse
model by cre-mediated targeted deletion of the Cerkl ﬁrst exon and proximal promoter. The excised genomic
region (2.3 kb) encompassed the ﬁrst Cerkl exon, upstream sequences including the proximal promoter and
the initial segment of the ﬁrst intron. The Cerkl−/−mice were viable and fertile. The targeted Cerkl deletion
resulted in a knockdown more than a knockout model, given that alternative promoters (unreported at that
time) directed basal expression of Cerkl (35%). In situ hybridizations and immunohistochemistry showed that
this remnant expression was moderate in the photoreceptors and weak in the ganglion and inner cell layers.
Morphological characterization of the Cerkl−/− retinas did not show any gross structural changes, even at
12 months of age. However, some clear and consistent signals of gliosis and retinal stress were detected by
the statistically signiﬁcant increase of i) the glial ﬁbrillary antigen protein (GFAP) expression, and ii) apoptosis,
as detected by TUNEL. Remarkably, consistent non-progressive perturbation (from birth up to 12 months of age)
of ganglion cellswas supported by the decrease of the Brn3amarker expression aswell as the reduced oscillatory
potentials in the electroretinographic recordings. In conclusion, the Cerkl−/− knockdown shows a mild retinal
phenotype,with increased levels of cellular stress and apoptosis indicators, and clear signs of functional alteration
at the ganglion cell layer, but no detectable morphological changes.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Mutations in the CERKL gene are associated to autosomal recessive
retinal degeneration. First characterized as a Retinitis Pigmentosa (RP)
causing gene [1–6], and later also considered to promote Cone-Rod
Dystrophy (CRD) [7,8], its classiﬁcation as a RP or CRD gene is still
under question. In fact, although the association of CERKL mutations
with retinal pathology is clear, we are still at the dark concerning its
physiological function and contribution to the progressive photoreceptor
degeneration.
CERKL [6] was named after the amino acid identity conservationwith
CERK [9], the reported ceramide kinase enzyme, known to phosphorylate
the sphingolipid ceramide to ceramide-1-phosphate (C1P) [10], whoseDuarte), roman.blanco@uah.es
l rights reserved.balance acts as cellular rheostat between apoptosis versus survival
signaling pathways [11–13]. AlthoughCERKLhas an intact diacylglycerol
kinase domain [6,14], no kinase activity neither on lipids nor proteins,
could be assigned after intense studies from many groups [14–16].
Remarkably, overexpression of CERKL in cultured cells confers protection
against apoptosis caused by oxidative stress injury, providing the ﬁrst
experimental clues on its role in retinal cell protection [16].
Very recently, an accurate assessment of the transcriptional products
has unveiled that CERKL shows a high repertoire of transcript isoforms
due to a combination of extensive alternative splicing plus the use of
at least three additional promoters [17]. Adding to the complexity
of CERKL functional analysis, the protein subcellular localization is
extremely dynamic, shifting from the cytoplasm – where it mainly
localizes associated to the endoplasmic reticulum and Golgi mem-
branes – to the nucleus, and seldom at the nucleoli [16].
CERKL shows a wide tissular expression although the tissues
where the expression is highest are retina in humans and retina and
liver inmouse [17]. In situmRNAhybridization onmouse retinal sections
showed strong Cerkl speciﬁc expression in the ganglion cell layer (GCL),
moderate and interspersed staining in the inner nuclear layer (INL), and
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nohistochemistry with antibodies against speciﬁc epitopes revealed
strong CERKL colocalization with cones, fainter in rods, and moderate
at the INL and GCL.
Our group ﬁrst identiﬁed the R257X mutation in CERKL [6], which
it is also the most frequent and accounts for more than half of the
reported mutated alleles [17]. This mutation is located on exon 5,
one of the alternatively spliced exons, and thus some but not all
protein isoforms are compromised. To evaluate the phenotype of
this mutation, a mouse model in which exon 5 had been excised was
constructed [18]. The homozygous exon 5-deleted mice did not
show any apparent phenotype in the retina.
In this context, to shed light on CERKL physiological role and the
in vivo consequences of its mutations, we aimed to generate a full
knockout Cerkl−/− mouse model by targeted deletion of the
reported promoter and the ﬁrst exon, according to the knowledge at
that time. However, the use of alternative promoters driving residual
transcription in the retina turned our knockout into a knockdown
model retaining 30–35% of CerklmRNA isoforms, all of them lacking the
ﬁrst exon and initiating methionine. The homozygous exon 1-deleted
Cerkl−/− mice show increased levels of retinal stress and apoptosis,
and diminished expression of the ganglion cell marker Brn3a, but no
grossmorphological retinal alterations.Most interestingly, the electroret-
inographic changes observed in the oscillatory potentialwaveforms are in
accordance with the reduced levels of Cerkl mRNA and Brn3a protein
levels in the retina of the KO mice.
2. Material and methods
2.1. Animal handling, tissue dissection and preparation of samples
Murine tissue samples were obtained from Cerkl+/+ and Cerkl−/−
C57BL/6J background mice. All procedures were performed according
to ARVO statement for the use of animals in ophthalmic and vision
research, as well as the regulations of the Animal Care facilities at the
University of Barcelona. Animals were euthanized with CO2 followed
by cervical dislocation. Speciﬁc tissues and organs were dissected and
immediately frozen in liquid nitrogen.
2.2. Generation of the knockout Cerkl−/− mouse model
The strategy, the generation of targeting constructs, initial ES cell
screening, breeding, housekeeping and molecular genotyping of all
the mice after the G0 generation as well as the crosses to obtain the
knockout animalmodel have been performed in our lab. ES transfection,
handling, and the generation of chimeric embryos for the obtention of
the founder mouse Cerkl+/− were performed by GenOway (Lyon,
France). A diagram of the targeted locus is depicted in Fig. 1A. In brief,
the genomic sequences corresponding to the 5′ and 3′ ﬂanking regions
of the Cerkl promoter and exon 1 were ampliﬁed from 129/SvPas geno-
mic DNA. These sequences were referred as long (region before exon 1)
and short (intron 1) arms of homology (LA and SA). Several sub-cloning
steps were performed to obtain the ﬁnal targeting vector using pPCR-
Script SK (+) vector (Stratagene). The ﬁrst step consisted in the
addition of a loxP site into LA. A synthetic exon 1 construct with new
restriction sites (GeneArt) was used to clone the ampliﬁed SA fragment.
A Neomycin resistance gene (NEO) ﬂanked by two FRT and one loxP
sites were also introduced into SA. Finally, both homology arms were
cloned together and the negative selection cassette, DTA (Diphteria
Toxin A), was added. The resulting targeting vector stretched 15384 bp,
was fully validated by sequencing, and was electroporated into 129Sv
ES cells. Positive selection was performed 24 h after electroporation by
adding geneticin (200 μg/ml), and more than 1000 geneticin-resistant
clones were isolated and ampliﬁed. After PCR screenings for recombina-
tion at the 5′ and 3′ ﬂanking regions, a total of 14 clones were obtained.
Thosewere characterized by Southern Blot using two different probes, 5′probe and 3′ probe (Fig. 1B). Only 5 clones had recombined at the correct
sites. ES positive cells were used for C57BL/6J blastocyst injections and
led to the generation of 9 male chimeras displaying a chimerism rate
ranging from 50 to 80%. Highly chimeric males (80% chimerism) were
mated with C57BL/6J Flp-deleter females to allow the excision of the
NEO selection cassette. Pups were genotyped, and those that presented
the excision of the cassette were breeded with wild-type C57BL/6J. The
ﬁrst generation of ﬂoxed mice was obtained by mating 2 heterozygous
ﬂoxed males with C57BL/6J Cre-deleter females to allow the germline
excision of the ﬂoxed region. Mice were subsequently bred with
C57BL/6J mice for a total of 5 generations and pups were genotyped by
PCR from tail or ear samples.
2.3. Genotyping by Southern blot and PCR
Genomic DNA from ES cells growing after double positive–negative
selection was obtained by standard protocols, after a mild lysis, over-
night proteinase K digestion and nucleic acid precipitationwith ethanol.
Ten micrograms of DNA were digested with informative restriction
enzymes, separated by agarose electrophoresis and transferred to Nylon
membranes. Standard protocols for pre-hybridization, hybridization
with 32P-labeled probes (whose position is indicated in Fig. 1A) were
used. Autoradiographic exposition and image acquisition were per-
formed with BioRad Molecular Imager FX Pro Plus (Bio-Rad, Hercules,
CA). Three PCR genotyping primers (Fw, Rv1 and Rv2, sequences in
Table 1) were used at the same time to allow genotyping of the WT
and the ﬂoxed alleles in a single reaction (Fig. 1D). The PCR reaction
included a ﬁrst denaturing step of 120 s at 94 °C, followed by 35 cycles
of 94 °C for 20 s, 59 °C for 30 s, and 72 °C for 60 s.
2.4. RNA extraction and RT-PCRs
Twenty-ﬁve milligrams of each frozen mouse tissue were homoge-
nized using a Polytron PT 1200 E homogenizer (Kinematica AG, Lucerne,
Switzerland). For total RNA extraction, High Pure RNA Tissue Kit (Roche
Diagnostics, Indianapolis, IN) was used, following the manufacturer's
instructions. Total RNA was quantiﬁed using the nanoquant plate in an
Inﬁnite 200 microplate reader (Tecan, Männedorf, Switzerland).
The RT-PCR assaywas carried outwith the TranscriptorHigh Fidelity
cDNA Synthesis Kit (Roche Diagnostics, Indianapolis, IN) performed
following the manufacturer's protocol, using 200 ng of mouse total
RNA. For tissue expression analysis all reaction mixtures (50 μl) con-
tained 10 μM of each primer pair, 2 μM of dNTPs, 1.5 mM MgCl2 and 1
U of GoTaq polymerase (Promega, Madison, WI). A pair of primers
was used to amplify mouse Gapdh (Table 1) to compare and normalize
the samples. Two-step PCR conditions were as follows: 120 s at 94 °C
and 30 cycles of 94 °C for 20 s and 63 °C for 120 s. Mouse Cerkl expres-
sion was detected with primers mRT_F and mRT_R (a ﬁrst denaturing
step of 120 s at 94 °C, followed by 35 cycles of 94 °C for 20 s, 60 °C for
30 s, and a ﬁnal extension step at 72 °C for 20 s). The characterization
of the different alternative promoters was performed on cDNAs using
a forward primer located in each promoter (NeuroD1_F, UTR_F, 3a_F
and 3b_F) and the same reverse primer in exon 12 mRT_R (Table 1).
Primers were designed to share the melting temperatures and opti-
mized for the same ampliﬁcation conditions: 120 s at 94 °C followed
by 40 cycles of 94 °C for 20 s, 58 °C for 30 s and 72 °C for 90 s. Oligonu-
cleotide sequences are listed in Table 1 and their localization is depicted
in Supplementary Fig. 1.
Real-time PCR was performed using the SYBR Green I Master assay
in a LightCycler480 (Roche, Indianapolis, IN). Speciﬁc primers in dif-
ferent exons were designed to generate an amplicon of approximately
100 bp. Oligonucleotide sequences are listed in Table 1. The expres-
sion of β-2-microglobulinwas used for normalization and comparison
to Brn3a and Gfap target genes. For each real-time PCR reaction, 2 μl of
cDNA (diluted 1:5), 1 μMof each primer, 1×mastermix andH2Owere
mixed in a ﬁnal volume of 10 μl. The reaction was pre-incubated for
Fig. 1. Targeting of the Cerkl locus. (A) Schematic representation of the Cerkl locus (drawn to scale), the region of interest encompassing the proximal promoter and ﬁrst exon, the
targeting vector and the targeted, ﬂoxed and deleted loci. Cerkl exons, Southern blot probes, restriction sites, oligonucleotides for genotyping are depicted. The targeting vector
contained the diphteria toxin A (DTA) and neomycin resistance (NEO) genes, the latter ﬂanked by two direct FRT target sites (dark gray ellipses). Two direct loxP sites (light
gray triangles) are at the boundaries of the proximal promoter, exon 1 and the NEO cassette. Mice carrying the Cerklneo allele were crossed to a transgenic CMV-Flp recombinase
strain to generate the Cerklﬂox heterozygotes, which were subsequently crossed with a CMV-Cre strain to obtain the Cerkl−/− chromosome. (B) Southern blot analysis of targeted
ES cells. External probes at 5′ and 3′ were used to verify homologous recombination. Digestion with PciI hybridized with the 5′ probe showed the WT (7.4 kb) and recombinant
(5.3 kb) alleles, whereas digestion with EcoRV and BglII with the 3′ probe produced 6.7 kb (WT) and 4.5 kb (recombinant) bands in clones C# 1, 2 and 3. (C) Southern blot of
the Cerkl+/− mice after the BglII digestion. The bands observed correspond to WT (6.7 kb) and KO recombinant (2.9 kb) alleles of 4 different heterozygous mice (M# 1, 2, 3
and 5). (D) PCR analysis of the ﬁrst generation mice obtained after breeding two Cerkl+/−. Primers F, R1 and R2 were used in the same PCR reaction. The wt allele produced a
band of 601 bp (ampliﬁed by F and R1), while the recombinant knockout allele generated a 354 bp band (ampliﬁed by F and R2). PCR conditions did not allow the ampliﬁcation
of the band corresponding to the WT allele using the F and R2 primers (2.6 kb).
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95 °C, 15 s at 62 °C and 10 s at 72 °C. Four replicates were carried out
per sample (containing the pooled retinas of at least three different
animals), together with their corresponding negative controls. Relative
quantiﬁcation of each gene transcription level was performed using the
second-derivative maximum method (LightCycler 480 software, ver.
1.5.0; Roche).2.5. In situ hybridization and immunohistochemistry on mouse retina
cryosections
Eyecups from 2 to 12 month-oldWT and KOmice were ﬁxed in 4%
paraformaldehyde (PFA) for 2 h at room temperature (RT), washed,
and cryoprotected in sucrose at 4 °C (successive incubations at 20%
for 30 min, 30% for 30 min and 40% sucrose for 12 h). Eyecups were
Table 1
Sequences of Cerkl primers used in the PCR reactions.
Name Forward primer sequence (5′→3′) Name Reverse primer sequence (5′→3′)
Cerkl and Gapdh tissue expression
Gapdh_F TGAAGGTCGGAGTCAACGGATTTGG Gapdh_R CATGTAGGCCATGAGGTCCACCAC
mRT_For CTGACTGTGGTGGTCACTGG mRT_Rev GAACCTCTGATGCAGCTTCC
NeuroD1_F TCAATTTTCCCTTTGTGGAGAC
UTR_F TGTAGCCACACTTCCTTCCCA
3a_F GTTTTGCTGCGTGGCATCTTC
3b_F GACGCATCCAGCCCGAGC
Riboprobes
Rho_F GCCCTTCTCCAACGTCACAG Rho_R GCAGCTTCTTGTGCTGTACGG
mRT_For CTGACTGTGGTGGTCACTGG mRT_Rev GAACCTCTGATGCAGCTTCC
Real Time PCR
β2M_F GTCTTTCTGGTGCTTGTCTCAC β2M_R CGTAGCAGTTCAGTATGTTCGG
Gfap_F CGCTGGAGGAGGAGATCCA Gfap_R ACATCCATCTCCACGTGGACC
Brn3a_F CCACCCTCCCTGAGCACAAGTA Brn3a_R CAGGCTGGCGAAGAGGTTGC
Genotyping
F ACACATTAGAAGCCCTGAAGGA R1 TCTTTGTGCTGTAGCAGTGACC
R2 TTGCTGTTTAATCCAGTTGTCCT
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and sectioned at −17 °C.
For in situ hybridization, 20 μm sections were recovered on poly-
lysine covered slides, dried at RT (30 min), rinsed twice with
phosphate-buffered saline (PBS) (10 min), treated with 2 μg/ml pro-
teinase K for 15 min at 37 °C, washed twice for 5 min with PBS, and
postﬁxed with 4% PFA. The hybridization was performed as described
previously [6] with some modiﬁcations: two steps of acetylation with
0.1 M triethanolamine–HCl (pH 8.0) containing 0.25% acetic anhydride
and 0.5% were performed (5 min each). The BM Purple AP Substrate
(Roche Diagnostics, Indianapolis, IN) reagents were used. Sections
were cover-slipped with Fluoprep (Biomérieux, France) and photo-
graphed using a Leica DFC Camera connected to a Leica DM IL optic
microscope (Leica microsystems, Germany).
For immunohistochemistry, 14 μm sections were recovered on
poly-lysine covered slides, dried for 1 h, washed in PBS (3×10 min),
and blocked in blocking solution (PBS containing 2% Donkey Serum,
0.2% Triton X-100) at RT (60 min). Incubation with primary anti-
bodies was performed overnight at RT in blocking solution. Sections
were rinsed three times in PBS again, followed by incubation with
the corresponding secondary antibodies conjugated to either Cy2 or
Cy3 (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA)
(1:200) at RT (90 min) in blocking solution too. After 3 washes,Fig. 2. Semi-quantitative expression analysis of Cerkl in wild-type and knockout mice. RT-PC
mRT_F and mRT_R, located in exons 9 and 12, respectively, and contained in all isoforms. P
(C) Semi-quantitative analysis of Cerkl expression in Cerkl+/+ and Cerkl−/−mice. Maximu
replicates were performed. Gapdh expression was used for normalization. Signiﬁcant decresections were incubated with DAPI (Sigma-Aldrich, Saint Louis, MO)
for 10 min and washed in PBS (3×10 min). Sections were cover-
slipped with antifading reagent and photographed with a confocal mi-
croscope (LEICA TCS-SP5, Wetzlar, Germany). Primary antibodies and
dilutions used were: 1:50 for Goat anti-Brn3a (Santa Cruz Biotechnolo-
gy, Inc., Santa Cruz, CA); 1:200 for mouse anti-Rhodopsin (BIOTREND
Chemikalien GmbH, Cologne, Germany); 1:200 for rabbit anti-PAX6
(Covance, Princeton, NJ) and rabbit anti-blue Opsin, 1:400 for rabbit
anti-red/green opsin (Millipore, Billerica, MA); 1:200 for the home-
made rabbit anti-CERKL (previously pre-absorbed) and 1:1000 for
mouse anti-Calbindin D (Sigma-Aldrich, Sant Louis, MO). GFAP immu-
nostaining was performed as described elsewhere [19] on P60 and
P280 WT and KO retina cryosections.
2.6. Protein level analysis
Retinas from P60 and P365WT and KOmice were homogenized in
RIPA buffer (50 mM Tris pH 7.5, 1 mM EDTA, 150 mM NaCl, 0.25%
Na-Deoxycholate, 1%NP40plus protease inhibitors). Thirtymicrograms
of protein were loaded onto 12.5% acrylamide gels. Western blots were
performed as described previously [16]. Primary antibodies were used
at the followingdilutions: 1:8000mouse anti-α-tubulin (Sigma-Aldrich,
Saint Louis,MO); 1:2500mouse anti-Rhodopsin and 1:2000mouse anti-R expression in several tissues of Cerkl+/+ (A) and Cerkl−/− (B) mice, using primers
rimer sequences are provided in Table 1. The amplicon size is indicated for each case.
m wild-type Cerkl levels were arbitrarily set as 100% (liver). At least three independent
ased expression is observed in all KO tissues except brain.
Fig. 3. Remnant Cerkl expression in the KO mouse is attained by the use of tissue-
speciﬁc alternate promoters. RT-PCRs were performed on wild-type and KO murine
samples to determine the activity of alternate Cerkl promoters in different tissues.
Different speciﬁc forward primers located at each of the transcription start sites previously
identiﬁed (NeuroD1 UTR, Cerkl UTR, 3a and 3b) were used in combination with the same
reverse oligonucleotide in exon 12. Overall Cerkl expressionwas assessed by ampliﬁcation
of a common region to all isoforms (Cerkl9–12).Gapdhwas used for normalization. Primer
sequences are provided in Table 1.
Fig. 4. Cerkl in situ hybridization on WT and KO mouse P60 retinas. (A) Representative
images (equivalent results in at least three independent replicate animals) of in situ
hybridizations with the antisense Cerkl probe on Cerkl+/+ (WT) which labels the
GCL, INL andmoremoderately, the inner photoreceptor segment (dark purple staining).
Note that the second panel with the Cerkl−/− (KO) retinas shows amuch fainter signal
in the GCL, INL and the inner photoreceptor segment (light purple staining). Negative
control with the sense Cerkl probe (C−) and positive control with the antisense
Rhodopsin probe (C+), which strongly labels the inner photoreceptor segment, are
also shown for comparison. PhR— Photoreceptor cell layer; ONL— outer nuclear layer;
OPL— outer plexiform layer; INL— inner nuclear layer; IPL— Inner plexiform layer;
GCL— ganglion cell layer.
1262 A. Garanto et al. / Biochimica et Biophysica Acta 1822 (2012) 1258–1269GAPDH (Abcam, Cambridge, UK); 1:2000 mouse anti-PKCα, 1:500 goat
anti-RDS, 1:1000 goat anti-Brn3a (Santa Cruz Biotechnology Inc., Santa
Cruz, CA); 1:2000 rabbit anti-PAX6 (Covance, Princeton, NJ); 1:2500
mouse anti-GFAP, and 1:2000 rabbit anti-green Opsin and anti-blue
Opsin (Millipore, Billerica, MA). Alpha-Tubulin and GAPDH levels were
used as normalization controls. Semi-quantiﬁcation of the bands was
carried out using the Quantity One Software (Bio-Rad, Hercules, CA).
Statistical signiﬁcance was analyzed by the Mann–Whitney and t-
Student tests.2.7. TUNEL analysis
Twelve micrometer thick cryostat sections of P60 animals were
rinsed in PBS, ﬁxed in ethanol and acetic acid (2:1) for 5 s at
−32 °C, then rinsed with PBS and incubated in PBS with 0.2% Triton
X-100 and 0.1% Sodium citrate for 15 min. After washing, retinal
sections were incubated in TUNEL buffer (30 mM Tris·HCl ph 7.2,
140 mM sodium cacodylate, 1 mM CoCl2, 0.3% Triton-X-100) for
30 min and terminal deoxynucleotidyl transferase (TDT) (800 U/ml)
and biotinylated dUTP (1 μM) (Roche Diagnostics, Indianapolis, IN)
were added and incubated at 37 °C. The reaction was terminated
with SCC×1 buffer and rinsed with PBS. Incubation with goat anti-
Brn3a (1:50) (Santa Cruz Biotechnology Inc., Santa Cruz, CA) was per-
formed overnight at room temperature. After washing in PBS, retinal
sections were again incubated in a solution containing the secondary
antibody anti-goat Cy3 and streptavidin conjugated to Cy2 (Jackson
ImmunoResearch Laboratories Inc., West Grove, PA, 1:200 each) for
1 h and 30 min at room temperature. The nuclei were counter-stained
with DAPI (Sigma-Aldrich, Saint Louis, MO) and rinsed with PBS.
Sections were cover-slippedwith antifading reagent and photographed
with a confocal microscope (LEICA TCS-SP5, Wetzlar, Germany). A
similar protocol was followed for whole-mount preparations.Fig. 5. CERKL, Brn3a and Calbindin immunohistochemistry of WT and KO retinas. Fluorescen
cell marker) and DAPI (nuclear staining) on 14 μm sections from P60 C57BL/6J and Cerkl−/−
retinas. E–H and M–P) KO retinas. The CERKL polyclonal antibody (B, F, J and N) reveals a fa
retinas. The ganglion Brn3a (C and G) and amacrine Calbindin (K and O) cell markers were
parts of Brn3a/CERKL and Calbindin/CERKL merged images are shown at the most right pane
and Calbindin and CERKL (L and P) in amacrine cells of INL and GCL. PhR— Photoreceptor cell
IPL— Inner plexiform layer; GCL— ganglion cell layer.2.8. Electroretinography
Prior to ERG recording, mice were adapted to the dark overnight.
Then, mice were anesthetized under dim red light by i.p. injecting a
solution of ketamine (95 mg/kg) and xylazine (5 mg/kg) and main-
tained on a heated pad at 37 °C. Pupils were dilated by topical appli-
cation of 1% tropicamide (Alcon, Spain) and ﬂash-induced ERG
responses were recorded from both eyes in response to light stimuli
produced with a Ganzfeld stimulator. The recording protocol consisted
of dark-adaptation for 20 min, after which scotopic ERG, maximum
ERG, and dark-adapted oscillatory potentials (OPs) were recorded.
After the dark-adapted ERGs, the eyes were light-adapted for 10 min,
and the photopic ERG and 30-Hz ﬂicker ERG were recorded. The out-
come measures were the response amplitudes and implicit time of
each ERG component.
The ERG complied with International Society for Clinical Electro-
physiology of Vision (ISCEV) standards [20]. Kruskal–Wallis and
Mann–Whitney U tests were used to estimate the level of signiﬁcance
for the difference in the ERG parameters among the study groups
as appropriate. The ERG signals were ampliﬁed and band ﬁltered
between 0.3 and 1000 Hz with a Grass ampliﬁer (CP511 AC ampliﬁer,
Grass Instruments, Quincy, MA, USA). Electrical signals were digitized
at 10 kHz with a Power Laboratory data acquisition board (ADIt immunodetection of CERKL, Brn3a (ganglion cell layer marker), Calbindin (amacrine
retinas. Photographs were taken in the central retina for comparison. A–D and I–L) WT
inter staining in the GCL, INL and the inner photoreceptor segment in the KO vs the WT
used. D, H, L, and P are the corresponding merged images. Magniﬁcations of signiﬁcant
ls. White arrows indicate colocalization of Brn3a and CERKL in the GCL layer (D and H),
layer; ONL— outer nuclear layer; OPL— outer plexiform layer; INL— inner nuclear layer;
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AgCl mouse electrode ﬁxed on a corneal lens (Burian-Allen electrode,
Hansen Ophthalmic Lab., IA, USA), a reference electrode located in the
mouth, and with a ground electrode located on the tail. The electrode
was mounted on a coarse micromanipulator for easy positioning over
the mouse eye. Impedance of active and reference electrodes were
less than 20 kΩ.
3. Results
3.1. Cerkl deletion of exon 1 and upstream sequences
The gene targeting strategy resulted in the cre-mediated excision
of a genomic region of 2.3 kb encompassing the ﬁrst Cerkl exon and
the beginning of the ﬁrst intron, plus 1.2 kb of upstream sequences
that stretched the reported promoter (Fig. 1A). Our strategy included
a ﬁrst step of FLP-mediated excision of the neoR selection gene in the
129/Sv ES cultured cells. All the homologous recombination events
performed in the ES cells were assessed by Southern blot analysis
(Fig. 1B) using informative restriction enzyme sites and probes speciﬁc
for the 5′ and 3′ events, depicted in Fig. 1A. Positive clones for the two
recombinant events were further conﬁrmed by speciﬁc PCR and
sequencing, and subsequently used to colonize C57BL/6J blastocysts.
Two chimaeric males were obtained and bred to obtain the ﬁrst hetero-
zygous animals (Fig. 1C), which after successive crosses produced the
homozygous null Cerkl−/− offspring at the expected mendelian ratio
(1:4). Genotyping of tail or ear samples from pups was performed by
a single PCR assay (primers indicated in Fig. 1A and Table 1) that
allowed the simultaneous ampliﬁcation of the wild-type and ﬂoxed
knockout alleles (Fig. 1D) (see Material and methods for details).
3.2. Assessment of Cerkl expression in knockout animals
To assess the abolishment of Cerkl expression in the knockout
mice, we performed an RT-PCR assay using primers located at the 3′
end of the cDNA, a region common to all the Cerkl isoforms reported so
far. Contrary to our expectations, the deletion of the reported promoter
did not completely abrogate Cerkl expression, as a faint band could be
observed in retina. These surprising results prompted us to assess the
levels of expression in several tissues of the knockout versus the wild-
type counterparts (Fig. 2A and B).
A semi-quantitative analysis of these results revealed a 65% decrease
of Cerkl levels in the KO retinas supporting a knockdown model more
than a complete knockout (Fig. 2C). Notably, this decrease in Cerkl
mRNA levels was not homogenous for all tissues, indicating that other
promoters, showing tissue speciﬁcity, contribute to the ﬁnal Cerkl
levels, which is in agreement with recent results showing that at least
3 additional promoters drive Cerkl expression in mouse and human
[17].
Moreover, a multiple band pattern was observed in some tissues,
such as retina, liver, spleen and testis. These bands were excised
and sequenced, and correspond to alternatively spliced transcript
isoforms, also in agreement with previous data [17].
Once the different Cerkl promoters had been identiﬁed, we aimed
to assess the contribution of each one to the levels of Cerkl expression
in the different tissues of the KO mice compared to the wild-type
controls. Indeed, as expected by the design of the targeting and the
genotyping of the KO mice, no transcripts from the reported Cerkl
promoter were observed in any tissue (Fig. 3, UTR). Concerning the
expression of Cerkl in the KO retina, residual transcription from the up-
streamNeuroD1gene and internalCerkl3apromoters can be detected at
similar levels than the WT retinas, accounting for the 30–35% of the
total Cerkl transcripts (Figs. 2 and 3). The major isoforms in Cerkl−/−
retinas are two transcripts starting at NeuroD1 and one from the inter-
nal 3a promoter, indicated with a symbol (#) in the Supplementary
Fig.1.Although no compensatory transcriptional activation from the
alternative promoters in the KO tissues was detected, moderate tran-
scriptional differences were observed, such as decreased expression
in kidney and testis from 3a and 3b, increased expression in spleen,
and speciﬁc isoform patterns in liver and testis (Fig. 3).
3.3. Morphological analysis of the KO retina
Retinal sections of KO mouse obtained at 2, 4 and 12 months
stained with hematoxylin/eosin did not show any gross morphological
differences neither in the cell layer organization, nuclei density or
photoreceptor outer segment length, when compared to WT animals
of the same age (Supplementary Fig. 2A). Nuclear counts after staining
with DAPI visualized in the confocal microscopy did not reveal any
signiﬁcant difference in the density and distribution through all the
layers at four different retina eccentricities (Supplementary Fig. 2B).
The localization of Cerkl expression products was then addressed
to assess possible differences in intensity/distribution throughout
the retinal cell layers. To this aim, in situ mRNA hybridization was
performed with a riboprobe against the shared RNA region of all iso-
forms (stretching exons 8 to 12), using Rhodopsin antisense and Cerkl
sense riboprobes as positive and negative controls, respectively. In
agreement with previous ﬁndings, WT endogenous Cerkl is mainly
detected in the GCL, and moderate expression at the inner segment
of photoreceptors (PhR) and the INL (Fig. 4). As expected, Cerkl
mRNA levels is decreased in the retina of the KO mouse, as shown
by a considerable decrease in hybridization intensity compared to
the WT controls, treated and stained under the same conditions and
time (Fig. 4). Notably, the more prominent decrease is observed in
the GCL, followed by the INL and much less in the PhR, indicating
that there is not a homogeneous decrease in Cerkl expression.
3.4. Immunolocalization of CERKL
Immunodetection of adult mouse retinas with an in-house anti-
CERKL polyclonal antibody (raised against a peptide encoded in
mouse Cerkl exon 2) indicated that CERKL localized in the GCL, INL,
and PhR (Fig. 5). In photoreceptors and INL cells, CERKL was shown
to be exclusively located in the cytoplasm and no nuclear staining
was observed in these cell types, as it has been described before
[21]. A fainter staining in the GCL, INL and the photoreceptor layer
with our CERKL polyclonal antibody was observed in the KO retinas.
Immunohistochemical stainings using antibodies against Brn3a and
Calbindin, speciﬁc retinal cell markers, showed cytoplasmic colocali-
zation of CERKL with a population of ganglion and amacrine cells
but no apparent change in the number and/or distribution of stained
cells (Fig. 5). A similar analysiswith the retinal cellmarker PAX6did not
show any expression pattern alteration either (Supplementary Fig. 3).
Cerkl−/−mouse retinas did not show any sign of rod and cone degen-
eration after rhodopsin/opsin immunostaining, even at 12 months of
age (data not shown). Besides, the photoreceptor outer segment length
(average∼22 μm), diameter and density were preserved, consistent
with neither photoreceptor degeneration nor apoptosis (data not
shown).
Given that no clear signals of apoptosisweredetected in theCerkl−/−
retinas, and that previous results from our group showed that over-
expression of CERKL protected cells against oxidative stress injuries
[16], we searched for other signals of retinal stress. Glial ﬁbrillary acid
protein (GFAP) expression is usually restricted to Müller cell endfeet in
the inner limiter membrane [19], but its expression is increased and
may extend to other retinal cell layers upon aging and retinal stress.
Immunohistochemistry analysis on P60 and P280WT and KO retinas
was performed. Differences in GFAP distribution and expression
between WT and KO retinas were very slight, although the expected
increase of GFAP with age was clearly detectable in both WT and KO
retinas (Supplementary Fig. 4).
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To assess the effects of the diminished Cerkl expression on several
retinal markers, indicative of structural/functional alterations in retinal
cell layers, we performed a semi-quantitative immunodetection on
Western blots in P60 WT and KO retinal lysates. Markers of the func-
tional status of: cones and rods (green opsin, blue opsin and rhodopsin),
ganglion (Brn3a), amacrine/ganglion (PAX6) and bipolar (α-PKC) cells,
and retinal stress (GFAP)were immunodetected and analyzed (Fig. 6A).Fig. 6. Semi-quantiﬁcation by Western blot of retinal proteins in WT and KO mice. (A) Thir
with antibodies against the green and blue opsins, rhodopsin, GFAP, Brn3a, PAX6 and α-P
quantiﬁed proteins are depicted in the histograms. For each age, WT levels were considere
(C) Immunodetection and quantiﬁcation of GFAP and Brn3a markers in lysates of P365 WT
of GFAP and Brn3a at P60 (100%) and P365 between WT and KO. GFAP levels were incre
(* pb0.05, t-Student). No statistically signiﬁcant differences were observed in Brn3a level
(E) and Brn3a (F) transcriptional levels in WT and KO retinas at P2, P30, P60 and P270. β-2
levels were considered as 100%. Each value contained the mRNA of at least three different
t-Student).Notably, a statistically signiﬁcant decrease of Brn3a, but not of PAX6
was detected (Fig. 6B),which indicates a perturbed structural/functional
status of the ganglion cells, rather than amacrine cells. Moreover, the
GFAP expression is clearly increased, revealing higher levels of retinal
stress in the Cerkl−/− animals. These results prompted us to analyze
the evolution of these altered expression levels with age (Fig. 6C). In
one-year (P365) aged animals, the decrease of Brn3a expression
remains consistent and at comparable levels than those of P60 mice.
Concerning GFAP, relative differences between WT and KO retinas arety micrograms of P60 protein lysates of WT and KO mice retinas was immunodetected
KC proteins. Tubulin and GAPDH were used as controls for normalization. (B) Semi-
d as 100%. Only GFAP and Brn3a showed signiﬁcant differences (* pb0.05, t-Student).
and KO mice retinas. For each age, WT levels were considered as 100%. (D) Expression
ased in aged animals, although the ratio WT/KO appears to be maintained (45–50%)
s between P60 and P365 animals. (E and F) Quantitative RT-PCR assessment of Gfap
-microglobulin levels were used for normalization between samples. For each age, WT
animals, and at least four different replicates were analyzed for each point (* pb0.05,
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GFAP levels increase proportionally in the two groups due to aging
(Fig. 6D).
To further support the decrease of Brn3a and increase of GFAP
expression in WT and KO retinas, we assessed the levels of tran-
scription of their corresponding genes by quantitative RT-PCR, in-
cluding β-2-microglobulin as a normalization control. In addition,
to test whether these differences in expression were constitutive
or progressive during retinal development until maturation, several
earlier time points (postnatal days 2 and 30) were added to the
analysis. The transcriptional analyses reinforced the data gathered
by protein levels immunodetection. Thus, KO retinas showed a pro-
gressive increase of Gfap expression (compared to WT retinas), in-
dicative of more vulnerability to retinal stress with age (Fig. 6E). In
contrast, the diminished Brn3a transcription levels appear to be a con-
stitutive trait of the KO retinas, as it is already evident as early as in P2
animals, and the difference with the WT retinas is maintained with
age (Fig. 6F).
The fact that no differences are observed in the other protein
markers analyzed highlights that the effect on Brn3a and GFAP
expression is speciﬁc and reﬂects the altered status of the KO
retinas.3.6. TUNEL analysis
To assess whether this altered status of the Cerkl−/− retinas was
also reﬂected in an increase of cell death, the levels of apoptosis were
analyzed by TUNEL staining on whole-mount and retinal sections
(Fig. 7A and B, respectively). Twelve retinal regions on the whole-
mounts were selected for systematic counting and analysis for each
eye from a total of three animals in each experimental group.
Increased levels of apoptotic cells (more than two-fold) were clearly
observed in the KO vs WT retinas (Fig. 7A), and this increase was
statistically signiﬁcant (Fig. 7C, pb0.01). In order to elucidate whether
the observed decrease in Brn3a expression correlated with speciﬁc
death of the Brn3a subset of ganglion cells, co-immunostaining in
retina sectionswas performed (Fig. 7B). Our results show that apoptosis
affects some but is not restricted to Brn3a positive ganglion cells, indi-
cating that the Cerkl−/− retinal perturbation involves different cell
types.3.7. Electroretinographic characterization of the KO retinas
The ERG experiments were performed in 10 C57BL/6J and 12
Cerkl−/− mice, measured four times at 2–3 months of age and at
3 month intervals until the animals reached 12 months. The ERG did
not show signiﬁcant differences between Cerkl−/− and WT mice
through time in response amplitudes and implicit times neither for
scotopic ERG, maximum ERG a- and b-waves, nor for photopic
single-ﬂash a-wave and 30-Hz ﬂicker ERG. Interestingly, a signiﬁcant
decrease in the amplitudes of oscillatory potentials (OPs) in the
Cerkl−/−mice was observed (Fig. 8). Although the frequency analysis
showed no signiﬁcant differences in the power spectral density at
different frequency bands (0–60, 60–120 and 120–180 Hz) (data not
shown), most OP components (OP2–OP4) were signiﬁcantly reduced
in amplitude and increased in implicit time in the KO compared with
WT animals (Pb0.05, Mann–Whitney test). These changes were ﬁrst
seen at P60 and remained consistent at P180 and up to P360, but
showed no progression. Most interestingly, the OP/a and OP/b ratios
in the KO animals did differ signiﬁcantly compared to amplitudes mea-
sured in age-matchedwild-type C57BL/6Jmice (Pb0.05,Mann–Whitney
test). Together with the same b/a ratio values in both strains, it could be
suggested that the neuronal circuitries of the inner retina aremoderately
affected in this Cerkl−/−model.4. Discussion
Mutations in human CERKL cause progressive retinal degeneration
leading to CRD or RP [1–8]. Despite a close structural similarity with
CERK, all the attempts to characterize its putative lipid kinase enzy-
matic activity have failed so far [14–16]. Taking into consideration:
1) the high transcriptional complexity of CERKL; 2) the large range of
protein isoforms, which display different domains; 3) the wide retinal
expression pattern of Cerkl, not exclusive of photoreceptors; and 4) the
highly dynamic nuclear–cytoplasmic protein localization, all together
underscore the challenge behind the dissection of the CERKL functional
role and contribution to retinal dystrophies.
Following the conventional approach for functional analysis of
human genes associated to hereditary diseases, we aimed to generate
a novel knockoutmousemodel, Cerkl−/−. Other authors had previously
attempted to emulate the most common mutation allele (R257X) by
deleting exon 5, but this model did not show any retinal phenotype
nor alterations in the levels of ceramide/C1P in the retina [18]. The
lack of ocular phenotype could be explained by the fact that this exon
is alternatively spliced and thus, the remaining isoforms could perform
some of the Cerkl roles [17]. Therefore, we aimed to construct a total
knockout model by a loxP/cre-based deletion of the Cerkl ﬁrst exon
plus 1.2 kb upstream region that encompassed the proximal promoter
and transcriptional initiation site.
Although the gene targeting was successful, Cerkl expression could
not be completely abrogated. Unfortunately, some basal transcription
(around 30–35%) was driven by previously unreported alternative
promoters, among them that of NeuroD1 gene, which accounts for
most of the remaining Cerkl expression in the KO mice retina. This
promoter is located upstream the Cerkl gene, transcribes the same
DNA strand, and is highly active in the Central Nervous System
(CNS). Sequencing revealed that these transcripts started at the 5′
UTR ﬁrst exon of the NeuroD1 gene, followed by a cryptic intergenic
173-bp exon joined to Cerkl exon 2. The fact that this cryptic exon
contains several methionines, one of them in frame, supports that
some CERKL could be present in the KO retina. In this respect, evi-
dences that other CERKL initiating methionines could be recognized
in vivo in other isoforms have already been gathered in human [17].
Indeed, the Cerkl isoforms arising from this promoter could explain
the mild retinal phenotype, beﬁtting more a knockdown than a knock-
out model.
Overall, our results indicate that in the retina the alternative pro-
moters (NeuroD1 and Cerkl 3a and 3b) donot show transcriptional com-
pensatory activity in the KOmice (Fig. 3). However, small differences in
the Cerkl expression pattern could be detected in other tissues: a slight
increase could be detected in testis, and new isoformswere apparent in
kidney, liver, and testis. Either the deletion of upstream Cerkl sequences
or changes in the relative position of the proximal regulatory elements
in the ﬂoxed allele may account for these differences. Further work is
required to assess the validity of these hypotheses.
In our electroretinographic studies, ERG amplitudes and latencies of
scotopic a-waves and b-waves, and photopic b-waves in the Cerkl−/−
were not signiﬁcantly decreased compared to age-matched WT mice,
which indicated that the basic pathways of phototransduction and
signal transmission in the outer retina were unaffected. However, the
consistently observed differences in the OPs (high frequency (90–
160 Hz), low amplitudewavelets on the rising edge of the electroretino-
gram (ERG) b-wave) pointed to functional alterations in the inner plex-
iform layer (IPL), even though the morphology was preserved.
Multiple cell types in the inner retina – in particular at the IPL
[22] – could contribute to OPs, but amacrine and/or ganglion cells
are the largest contributors [23,24]. In this context, early and late
components of OPs appear to be modulated independently [25,26],
and may reﬂect the functional contribution of these two distinct cell
groups. In the KO animals, late OP components (OP3)were signiﬁcantly
reduced in amplitude and increased in implicit time (Fig. 7). Notably, it
Fig. 7. Increased apoptosis in the P60 Cerkl−/− retinas. (A) Nasal region images of TUNEL analyses performed on whole-mount retinas of the Cerkl−/− (KO) and wild type (WT)
animals, focused on the GCL. (B) Double staining of Brn3a and TUNEL positive cells in sections of the Cerkl−/− (KO) retinas. Arrowheads indicate the colocalization of the different
labels in a ganglion cell. Note that neither all TUNEL positive cells are Brn3a positive, nor apoptosis is restricted to Brn3a cells. (C) TUNEL positive cell counts for WT and KO retinas
(twelve different regions per retina and three different animals per group). Statistically signiﬁcant differences (* pb0.01, t-Student test) were observed.
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Fig. 8. Electroretinographic responses from control C57BL/6J (black) and Cerkl−/−mice (red) at P120. (A) Superimposed response waveforms of various ERG components from one
control (black traces) and one Cerkl−/− mouse (red traces): Rod responses to light ﬂashes of −2.09 log cd s m−2 and mixed responses (rod and cone) to light ﬂashes of
1.57 log cd s m−2 were recorded under dark adaptation. Cone responses (photopic ERG, oscillatory potentials and 30 Hz) Flicker) were recorded under light adaptation to light
ﬂashes of 1.57 log cd s m−2. Horizontal calibration: 100 ms; vertical calibration: 50 μV. (B) Histogram representation of the power spectral density (PSD) (mean and SD) of
Oscillatory Potentials measured in C57BL/6J Cerkl+/+ (n=8) and Cerkl−/− animals (n=8) (* pb0.05, Mann–Whitney test).
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dendritic stratiﬁcation at the IPL, with very moderate ganglion cell loss
[27]. Given that dentritic arborization correlates with physiological
responses, the decrease of Brn3a (apparently constitutive in our
model) could be the cause of the observed OP alterations. Therefore,
our data favors alteration of ganglion over amacrine cells on the
grounds of reduced OP waveforms, decreased expression of Brn3a and
unperturbed levels of PAX6 and calbindin. We cannot rule out that
other retinal cell types might be functionally disturbed, as reﬂected by
the increased apoptosis and higher expression of the retinal stress
marker GFAP.
Why the mouse Cerkl−/− retinal phenotype differs from that of
human patients? In order to answer this question, it may be relevant
to compare the gathered data. First, adult mouse retinas mainly
express Cerkl in the GCL ([6] and this work) and the Cerkl−/− retina
alterations point to ganglion cell affectation; in contrast, the analysis
of the human CERKL patients has revealed that GCL thickness and
altered nerve ﬁber layer (NFL) only appears at late disease stages
[2,7]. Second, a thickening of the superﬁcial hyperreﬂective layer
normally ascribed to the retinal nerve ﬁber layer (NFL) has been
observed in patients, most probably due to increased glial processes
[7]; in contrast, the increased gliosis (higher GFAP immunoreactivity)
observed in the KOmice retinas did not relate to NFL hyperreﬂectivity.Third, concerning photoreceptor functional integrity, while full-ﬁeld
ERGs with negative waveforms (greater b- than a-wave amplitude
reduction) are a feature of severely affected CERKL patients [7], this
alteration could not be observed in our KO model (in agreement
with preservation of rods and cones at the analyzed times), and only
OP components appear reduced. All these observations could be
reconciled if human and mouse retinas respond differently to the
same genetic defect and/or to stress insults. Other explanations for
this mild ocular phenotype in our Cerkl−/− mouse may rely on Cerkl
being partially redundant in mouse – so that other genes compensate
for its deletion –, or on species-speciﬁc expression patterns at the
retinal level — so that the phenotype caused by mutations in mouse
does not have to abide to the severity observed in humans. Indeed,
the same type of arguments has also been proposed for knockout
models of other RD-causative genes with no phenotypic visual alter-
ations, such as the Rdh12, Gcap2 and Gcap1/2 KO mice [28–31].
In summary, our Cerkl−/−model shows consistent perturbation of
theGCL, as reﬂected by alteredOPwaveforms and lower levels of Brn3a,
a POU-homeobox transcription factor involved in synaptogenesis and
axonogenesis [27,32,33]. These results together with the consistent
increased retinal stress and apoptosis signals observed in Cerkl−/− ret-
inas further expand the role of Cerkl to the homeostasis, preservation
and physiology of retinal neurons.
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